Ebrahim, N.A.A. et al. 2025. Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment. Asian Pacific Journal of Cancer Biology. 10, 3 (Aug. 2025), 689–698. DOI:https://doi.org/10.31557/apjcb.2025.10.3.689-698.